H.Y. Park
Recent publications
-
Ali, W., Choe, K., Nasir, T., Atiq, U., Tahir, M., Ahmad, W., Park, H. Y., Park, T. J., & Kim, M. O. (2026). Atraric acid mitigates the cognitive and pathological deficits in mice via Aβ 1−42 induced Alzheimer’s disease. Inflammopharmacology, 34(4), 2693-2704. https://doi.org/10.1007/s10787-026-02182-wMore information about this publication
-
Choe, K., Ali, J., Park, H. Y., Jang, S. H., Choi, E. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2026). The mGluR2/3 agonist xanthurenic acid improves memory, attention, and synaptic deficits by modulating glutamate release in Alzheimer's disease model. Acta Pharmacologica Sinica, 47(3), 625-635. https://doi.org/10.1038/s41401-025-01671-yMore information about this publication
-
Ahmad, R., Choe, K., Park, H. Y., Ahmad, W., Park, T. J., & Kim, M. O. (2026). Lupeol restores dopaminergic function by suppressing glial activation in a Parkinson's disease mouse model. Frontiers in Immunology, 17, Article 1708581. https://doi.org/10.3389/fimmu.2026.1708581More information about this publication
-
Choe, K., Tahir, M., Kang, M. H., Park, H. Y., Ahmad, R., Park, T. J., & Kim, M. O. (2026). Osmotin-derived 9-amino-acid peptide alleviates α-synuclein and MPTP-induced glial cell activation mediated neuroinflammation, protecting dopaminergic neurons in Parkinson’s disease mice brain. Journal of Biomedical Science, 33(1), Article 13. https://doi.org/10.1186/s12929-026-01215-4More information about this publication
-
Ali, W., Choe, K., Rehman, I. U., Park, H. Y., Jang, S., Ullah, S., Park, T. J., & Kim, M. O. (2025). Sinomenine Hydrochloride Impedes Memory Impairments via Nrf2/HO-1-Mediated Inhibition of Oxidative Stress, Neuroinflammation and Apoptosis in Mice Brain. J. Neuroimmune Pharm., 20(1), Article 85. https://doi.org/10.1007/s11481-025-10243-0More information about this publication
-
Park, J. S., Choe, K., Ahmad, R., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2025). A Novel Aβ B-cell epitope Vaccine, Aβ1-10 with carrier protein OVA and KLH reduce Aβ-induced neuroinflammation mediated neuropathology in mouse model of Alzheimer's disease. Brain Behavior and Immunity, 129, 196-205. https://doi.org/10.1016/j.bbi.2025.06.001More information about this publication
-
Ali, W., Choe, K., Kang, M. H., Ali, J., Park, H. Y., Atiq, A., Ahmad, S., Park, T. J., & Kim, M. O. (2025). Neuroprotective effects of saikosaponin-A in ethanol-induced glia-mediated neuroinflammation, oxidative stress via RAGE/TLR4/NFkB signaling. Frontiers in Cellular Neuroscience, 19, Article 1625362. https://doi.org/10.3389/fncel.2025.1625362More information about this publication
-
Rehman, I. U., Park, J. S., Choe, K., Park, H. Y., Park, T. J., & Kim, M. O. (2024). Overview Of a Novel Osmotin Abolishes Abnormal Metabolic-Associated Adiponectin Mechanism in Alzheimer's disease: Peripheral and CNS Insights. Ageing Research Reviews, 100, Article 102447. https://doi.org/10.1016/j.arr.2024.102447More information about this publication
-
Ali, W., Choe, K., Park, J. S., Ahmad, R., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2024). Kojic acid reverses LPS-induced neuroinflammation and cognitive impairment by regulating the TLR4/NF-κB signaling pathway. Frontiers in Pharmacology, 15, Article 1443552. https://doi.org/10.3389/fphar.2024.1443552More information about this publication
-
Ali, J., Choe, K., Park, J. S., Park, H. Y., Kang, H., Park, T. J., & Kim, M. O. (2024). The Interplay of Protein Aggregation, Genetics, and Oxidative Stress in Alzheimer's Disease: Role for Natural Antioxidants and Immunotherapeutics. Antioxidants, 13(7), Article 862. https://doi.org/10.3390/antiox13070862More information about this publication